Feline Inflammatory Bowel Disease
Douglas C. Bronstad, DVM,
Diplomate, American College of Veterinary Internal Medicine
(Internal Medicine)
Feline inflammatory bowel disease (IBD) is a newly recognized disease and has been cited
in several recent papers in the veterinary literature. The increased recognition of
this unique disease has stimulated clinicians to include it in the differential diagnosis
when a cat presents with signs of vomiting, diarrhea, or weight loss. In my experience, it
is the most common chronic primary gastrointestinal (GI) disorder of cats.
Etiology
The cause of (IBD) is unknown, although numerous theories have been proposed. One favored
by most academicians is that this disease is an immune-mediated hypersensitivity reaction
to indiscriminate antigens, including enteric bacteria and dietary components. Response to
corticosteroids in the majority of the cases supports assertions of immune-mediated
disease. There is no evidence that this disease is heritable.
Pathophysiology and Histopathology
Inflammatory bowel disease is characterized by an infiltration of inflammatory cells in
the mucosal lining of the bowel (ie., stomach, intestines, or colon). Depending on the
degree of inflammation and their location within the bowel, these infiltrates can affect
the secretions, motility, and absorptive capacity of the bowel, creating an environment in
which vomiting and diarrhea may develop.
The inflammatory infiltrates can be quite variable, in terms of severity and cell type.
The most common cell types are lymphocytes and plasma cells. When both are present, the
infiltrate is termed lymphoplasmacytic. Eosinophilic infiltrates may be seen as the
primary infiltrating cell (i.e., eosinophilic gastroenteritis); however, this cell line is
more commonly seen as a component in a mixed population of cells that includes lymphocytes
and plasma cells. Neutrophils can also be part of a mixed inflammatory response and have
been suggested by one author to result from a microbial component of the disorder.
Terms often used by pathologists to describe this disease process include lymphocytic,
plasmacytic, lymphoplasmacytic, eosinophilic, suppurative (i.e., predominantly
neutrophilic), and commonly, a mixed inflammatory infiltrate. This disease is often
segmental, and the degree of infiltrate may vary considerable, depending on the biopsy
site. In order to make a definitive diagnosis of IBD multiple biopsies of the GI
tract may be required. The degree of mucosal infiltrate reported may not be a true
reflection of the severity of the disease process.
History, Clinical Signs, and Physical Examination
Historical background and clinical signs of IBD can be quite variable and often are vague.
The most common clinical signs noted in chronic or refractory cases are vomiting,
diarrhea, or both, but anorexia and weight loss may be the sole presenting complaints in
some cases. Vomiting is the most common clinical sign on presentation. The character
of the vomitus can be variable, and hematemesis is occasionally seen. Weight loss is also
a variable component of the disease. Many cats have not lost weight at the time of
presentation; however others may be severely emaciated owing to the chronicity of the
condition and the area of bowel involved, leading to a malabsorption syndrome. Diarrhea is
usually present when there is intestinal or colonic involvement, and the character of the
diarrhea depends on what area of the bowel is predominantly affected (i.e., small bowel
versus large bowel diarrhea). If the mucosal infiltrate is predominantly gastric or
duodenal, vomiting is the primary presenting clinical sign and stools may be normal.
An IBD cat can have variable physical findings, depending on a number of factors including
chronicity of the disease process and location of the disease in the bowel. The physical
findings may be unremarkable in some cases, whereas other affected cats present with more
severe changes, such as a thin to emaciated body condition, varying degrees of abdominal
tenseness, palpably thickened intestinal loops, mesenteric lymphadenopathy, and various
degrees of dehydration. It is very important for the veterinarian to do a complete organ
system review during the physical examination, to rule out concurrent disease processes.
Diagnosis
A minimum data base for all IBD cases should include a fecal examination, complete blood
count (CBC, biochemical profile including baseline thyroxine (T4), urinalysis, and survey
abdominal radiographs. It is important to screen for other disease processes that may be
causing the clinical signs.
Laboratory findings in cases of IBD can be variable; however, the majority of cases have
minimal laboratory changes. The complete blood count often is normal, although mild to
moderate leukocytosis may be seen. Eosinophilia is a nonspecific indicator of eosinophilic
gastroenteritis. Occasionally, mild elevations in alanine aminotransferase,
alkaline phosphatase, amylase, and lipase may be associated with IBD. Urinalysis usually
is normal. Survey abdominal radiography is often unremarkable, and barium GI contrast
studies may demonstrate normal to irregular mucosal lining abnormalities and thickened
intestinal walls. In most cases radiography is unrewarding.
A definitive diagnosis of IBD can be made only by mucosal or full-thickness intestinal
biopsy. Gastric, duodenal, or colonic mucosal biopsy can be easily obtained by fiberoptic
endoscopic techniques. However, many general practices cannot justify the expense of this
equipment and must rely on other techniques to acquire a biopsy or utilize a referral
center that has endoscopic capability. Full-thickness intestinal biopsy specimens can be
obtained via an exploratory celiotomy. Multiple areas of the bowel (i.e., gastric,
duodenal, jejunal, ileal) can be biopsied with this approach. At least two or three
specimens should be taken from various areas of the bowel at the time of surgery.
Since IBD is predominantly a mucosal disease, the gross appearance of the serosal side of
the bowel may be normal. Do not assume that the cat does not have IBD because the gross
appearance of the bowel is normal. Full-thickness biopsy specimens have the advantage of
histopathologically evaluating both the submucosal and serosal region. Endoscopic biopsy
is less invasive but limited to the mucosal side of the bowel and by the inability to
reach certain areas of the small intestine (i.e., jejunum).
Treatment
The treatment of choice for most cases of IBD is prednisone or prednisolone. The dosage
should he individualized, depending on the severity of clinical signs and the chronicity
of the problem. initially 1.0 to 2.0 mg/lb per day divided in two doses is recommended.
Reduction of the dose should he slow and gradual, especially in chronic
cases. For an average 10-lb cat 5 mg of prednisolone b.i.d. for 2 weeks, 5 mg s.i.d.
for 2 weeks, then 5 mg q.o.d. for 4 weeks or as needed for maintenance therapy is usually
recommended. The larger dose (2 mg/lb/day) can be used for severe or reftactory cases. The
most common mistakes made during treatment of IBD are starting with an insufficient dose
of prednisolone and not giving the drug long enough. Parenteral administration (i.e.,
intramuscular [IM] or subcutaneous [SQ] may he necessary for the initial 24 to 48 hours if
vomiting precludes absorption of orally administered medication. For fractious animals or
ones whose owners have difficulty administering oral medications, methylprednisolone
acetate (Depo-Medrol) may be tried. however, response to this varies.
Prophylactic antibiotic therapy may be indicated in cases of IBD. Criteria that determine
antibiotic use include the presence of peripheral leukocytosis, elevated hepatic or
pancreatic enzymes on the biochemical profile, bleeding from the GI tract, suspected
bacterial overgrowth or stagnant loop syndrome, and severe mucosal inflammatory changes
with a neutrophilic component. Two antibiotics that are often used in combination with
prednisolone therapy are amoxicillin (Amoxi-tabs) and metronidazole (Flagyl). Amoxicillin
has both aerobic and anaerobic bactericidal effects and is dosed at 5 to 10 mg/lb b.i.d.
for 10 to 14 days or as long as deemed necessary by the veterinarian. Metronidazole
is primarily an anaerobic bactericidal antibiotic and often shows dramatic clinical
response in combination with prednisolone therapy in refractory IBD cases. Metroniclazole
also has an antiprotozoan effect and aids in inhibiting cell-mediated immune responses in
the intestinal tract. For IBD therapy metronidazole is typically dosed at 5 to 10 mg/ lb
twice or thrice daily for 2 to 4 weeks, or as deemed necessary by the veterinarian. An
average cat would receive approximately a quarter to a half of a 250-mg tablet two or
three times a day.
Additional immunosuppression may be necessary in cases that are refractory to
prednisolone. Azathioprine (Imuran), may be added to the therapeutic regime at 0.14 mg/ lb
every other day in combination with prednisolone. Azathioprine is available only in
a 50-mg tablet; to achieve a small dose the tablet can be crushed and mixed in a palatable
liquid. Some vets use a dose of a quarter tablet (12.5 mg) every other day in an average
10-lb cat without severe complications, although this is about ten times the recommended
dose. Bone marrow suppression is a potential side effect of azathioprine therapy, and a
CBC should be monitored every 2 weeks during the first month, then monthly thereafter.
Most cats tolerate the drug well.
If colitis is a predominant part of the IBD, sulfasalazine (Azulfidine) can be added to
the regimen. The typical dose is 7 to 10 mg/lb b.i.d. or t.i.d. or approximately a quarter
of a 500-mg tablet at each dose for an average 10-lb cat. Potential side effects in cats
include anorexia and anemia. This drug must be administered more cautiously to cats than
it is to dogs.
If dietary allergens are a possible cause of IBD, a hypoallergenic diet is indicated.
Hypoallergenic diets (e.g., lamb and rice) may be indicated. Long-term dietary management
may be necessary in chronic IBD cases. Low-gluten diets that have been suggested include
Science Diet Feline Maintenance. Other recommended diets are Nature's Receipe Rabbit and
Prescription Diet Feline c/d. Bran supplementation has also been suggested for
colitis. Novel and single-protein diets have also been used with success.
You and your veterinarian must use clinical judgment and gauge response to dietary
changes via trial and error.